Variances in BCG protection against COVID-19 mortality: A global assessment.
J Clin Tuberc Other Mycobact Dis
; 24: 100249, 2021 Aug.
Article
in English
| MEDLINE | ID: covidwho-1253158
ABSTRACT
The BCG vaccine is known to impart nonspecific immunological benefits alongside conferring protection to tuberculosis in endemic regions. It is also known to protect against bladder cancer and other respiratory tract infections. During the coronavirus disease 2019 (COVID-19) pandemic, the BCG vaccine has gained attention due to its role in conferring protective immunity. We demonstrate the potential immunological protective mechanisms that play a role against COVID-19. We conduct a global assessment of the countries that have the highest and lowest mortality rates determined by an a priori methodology. Lastly, we discuss the potential limitations of incorporating BCG vaccines as potential strategies against COVID-19 and provide recommendations regarding their use in ongoing and future epidemics.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Topics:
Vaccines
Language:
English
Journal:
J Clin Tuberc Other Mycobact Dis
Year:
2021
Document Type:
Article
Affiliation country:
J.jctube.2021.100249
Similar
MEDLINE
...
LILACS
LIS